We are live on ! Find out more
PA

Probity Advisors Portfolio holdings

AUM $699M
1-Year Est. Return 24.25%
This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+24.25%
3 Year Est. Return
+55.84%
5 Year Est. Return
10 Year Est. Return
AUM
$624M
AUM Growth
+$7.55M
Cap. Flow
-$3.69M
Cap. Flow %
-0.59%
Top 10 Hldgs %
43.3%
Holding
243
New
8
Increased
74
Reduced
142
Closed
11
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLYV icon
26
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.07B
$5.17M 0.83%
56,814
+2,289
+4% +$206K
IBDR icon
27
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.39B
$5.02M 0.8%
207,223
+45,562
+28% +$1.1M
IBTG icon
28
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
$2.22B
$4.78M 0.77%
209,102
+42,796
+26% +$980K
AVGO icon
29
Broadcom
AVGO
$1.99T
$4.5M 0.72%
12,995
-1,806
-12% -$646K
SLYG icon
30
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.26B
$4.31M 0.69%
45,797
+3,110
+7% +$294K
VUG icon
31
Vanguard Morningstar Growth ETF
VUG
$230B
$4.25M 0.68%
52,284
-2,298
-4% -$186K
IDEV icon
32
iShares Core MSCI International Developed Markets ETF
IDEV
$32.2B
$4.08M 0.65%
49,415
-666
-1% -$54.1K
VBK icon
33
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.1B
$3.96M 0.63%
13,121
-193
-1% -$58.2K
IBDZ
34
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$869M
$3.78M 0.61%
143,370
+1,329
+0.9% +$35.2K
IBDX icon
35
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.72B
$3.67M 0.59%
143,681
-1,517
-1% -$38.8K
IBDY icon
36
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.1B
$3.66M 0.59%
140,020
-1,049
-0.7% -$27.5K
GS icon
37
Goldman Sachs
GS
$311B
$3.54M 0.57%
4,026
-319
-7% -$260K
IBTM icon
38
iShares iBonds Dec 2032 Term Treasury ETF
IBTM
$560M
$3.5M 0.56%
151,891
-4,217
-3% -$97.8K
IBTO icon
39
iShares iBonds Dec 2033 Term Treasury ETF
IBTO
$464M
$3.49M 0.56%
142,201
-3,479
-2% -$86K
EFA icon
40
iShares MSCI EAFE ETF
EFA
$79.3B
$3.17M 0.51%
33,009
-411
-1% -$39K
LLY icon
41
Eli Lilly
LLY
$995B
$2.98M 0.48%
2,773
-383
-12% -$366K
ABBV icon
42
AbbVie
ABBV
$431B
$2.86M 0.46%
12,512
-567
-4% -$129K
ANET icon
43
Arista Networks
ANET
$240B
$2.85M 0.46%
21,774
-2,168
-9% -$298K
IBTP
44
iShares iBonds Dec 2034 Term Treasury ETF
IBTP
$286M
$2.85M 0.46%
110,486
+8,686
+9% +$226K
TXN icon
45
Texas Instruments
TXN
$259B
$2.8M 0.45%
16,167
-242
-1% -$41.4K
AMZN icon
46
Amazon
AMZN
$2.99T
$2.78M 0.45%
12,039
-102
-0.8% -$23.3K
BAC icon
47
Bank of America
BAC
$440B
$2.71M 0.43%
49,193
-1,669
-3% -$88.2K
SCZ icon
48
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
$2.63M 0.42%
33,886
-497
-1% -$38.1K
USB icon
49
US Bancorp
USB
$100B
$2.62M 0.42%
49,022
-978
-2% -$48.1K
GOOGL icon
50
Alphabet (Google) Class A
GOOGL
$4.62T
$2.59M 0.42%
8,281
-442
-5% -$126K

Similar funds

Probity Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Probity Advisors held 243 positions worth $624M, up 1.2% from $617M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Probity Advisors's Q4 2025 filing shows 8 new, 74 increased, 142 reduced and 11 closed positions. Its largest new stake was Clorox: 3,659 shares worth $369K. The largest sale was iShares iBonds Dec 2025 Term Corporate ETF, an estimated $3.91M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 7.9% a quarter earlier, followed by Healthcare and Financials.

  • Probity Advisors's largest Q4 2025 buy was Clorox: 3,659 shares worth $369K.
  • Probity Advisors added most to iShares iBonds Dec 2035 Term Corporate ETF in Q4 2025, an estimated $1.25M increase.
  • Probity Advisors's biggest Q4 2025 reduction was iShares S&P 500 Growth ETF, cutting an estimated $1.82M.
  • Probity Advisors fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q4 2025, selling an estimated $3.91M.
  • Probity Advisors's ten largest holdings make up 43% of its $624M portfolio in Q4 2025.
  • Probity Advisors opened 8 new positions and closed 11 in Q4 2025.
  • Probity Advisors's portfolio value rose 1.2% quarter-over-quarter to $624M.

Based on Probity Advisors's 13F filing for Q4 2025, filed 27 Jan 2026.